Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-26 FMR LLC Conversion +789,473 815,788
2021-10-26 FMR LLC Conversion +686,499 1,502,287
2021-10-26 FMR LLC Conversion +28,703 1,530,990
2021-10-26 FMR LLC Conversion +372,215 372,215
2021-10-26 FMR LLC Conversion +4,465 4,465
2021-10-26 FMR LLC Conversion · Series A Preferred Stock −7,500,000 0
2021-10-26 FMR LLC Conversion · Series A-1 Preferred Stock −6,521,739 0
2021-10-26 FMR LLC Conversion · Series B Preferred Stock −272,687 0
2021-10-26 FMR LLC Conversion · Series B Preferred Stock −3,536,046 0
2021-10-26 FMR LLC Conversion · Series B Preferred Stock −42,421 0

Page 1 of 1 · 10 trades